Home/Filings/4/0001209726-11-000006
4//SEC Filing

MOLEY KEVIN E 4

Accession 0001209726-11-000006

CIK 0000873364other

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 1:28 PM ET

Size

18.6 KB

Accession

0001209726-11-000006

Insider Transaction Report

Form 4
Period: 2011-10-14
Transactions
  • Disposition to Issuer

    Non-Qualified Stock Option

    2011-10-1415,0000 total
    Exercise: $59.18From: 2014-05-20Exp: 2020-05-20Common Stock (15,000 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option

    2011-10-1410,0000 total
    Exercise: $66.55From: 2013-05-12Exp: 2019-05-12Common Stock (10,000 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option

    2011-10-1415,0000 total
    Exercise: $60.08From: 2010-05-17Exp: 2016-05-17Common Stock (15,000 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option

    2011-10-1410,0000 total
    Exercise: $67.66From: 2012-05-22Exp: 2018-05-22Common Stock (10,000 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option

    2011-10-1415,0000 total
    Exercise: $79.85From: 2015-05-10Exp: 2021-05-10Common Stock (15,000 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option

    2011-10-1410,0000 total
    Exercise: $79.99From: 2011-05-17Exp: 2017-05-17Common Stock (10,000 underlying)
  • Disposition to Issuer

    Common Stock

    2011-10-141,0000 total(indirect: By Trust)
Footnotes (3)
  • [F1]Common Stock was converted pursuant to the Agreement and Plan of Merger, dated as of May 1, 2011, among Teva Pharmaceutical Industries Ltd., Copper Acquisition Corp. and Cephalon, Inc. (the "Merger Agreement") into the right to receive the Merger Consideration (as defined in the Merger Agreement) of $81.50 per share in cash.
  • [F2]Options were canceled at the Effective Time of the Merger pursuant to the terms of the Merger Agreement in exchange for a cash payment for each share subject to the option equal to the difference between the Merger Consideration of $81.50 per share and the exercise price of the option.
  • [F3]Reflects four-year anniversary from date of grant. Options vest 25% on each anniversary of grant and expire ten years from date of grant.

Issuer

CEPHALON INC

CIK 0000873364

Entity typeother
IncorporatedFL

Related Parties

1
  • filerCIK 0001086776

Filing Metadata

Form type
4
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 1:28 PM ET
Size
18.6 KB